Sale disclosed
Jamie L. Reynoso
CEO, Medicare Advantage
Class A Common Stock
- Reported value
- $9.29K
- Reported price
- $4.63 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
CLOVER HEALTH INVESTMENTS, CORP. /DE
Last 30 daysNo qualifying insider buying. Sales: $3M by 5 insiders.
Showing the first 6 of 20 trades on this page.
CEO, Medicare Advantage
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
VP OF FINANCE AND CONTROLLER
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
Chief Legal Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
VP OF FINANCE AND CONTROLLER
Class A Common Stock
Interim CFO
Class A Common Stock
Chief Legal Officer
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Interim CFO
Class A Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Class A Common Stock
Chief Legal Officer
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
Chief Executive Officer
Class A Common Stock
CEO, Counterpart Health
Class A Common Stock
CEO, Medicare Advantage
Class A Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 2,006$4.63 / share | $9.29K | Oct 7Filed Oct 7 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 8,750$4.42 / share | $38.68K | Oct 5Filed Oct 5 · 0d later | SEC filing |
| Director | Class A Common StockGrant or award | 12,481Award · no purchase price | Non-cash award | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Director | Class A Common StockGrant or award | 12,481Award · no purchase price | Non-cash award | Sep 30Filed Oct 2 · 2d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 318,806$4.19 / share | $1.34M | Oct 1Filed Oct 2 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 1,921$4.56 / share | $8.76K | Sep 17Filed Sep 18 · 1d later | SEC filing |
| VP OF FINANCE AND CONTROLLER | Class A Common StockSale10b5-1 | 3,170$4.64 / share | $14.71K | Sep 16Filed Sep 17 · 1d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockSale10b5-1 | 300,000$4.72 / share | $1.42M | Sep 15Filed Sep 16 · 1d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 6,846$4.78 / share | $32.72K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 9,273$4.78 / share | $44.32K | Sep 15Filed Sep 15 · 0d later | SEC filing |
| VP OF FINANCE AND CONTROLLER | Class A Common StockSale | 20,000$5.16 / share | $103.2K | Sep 14Filed Sep 14 · 0d later | SEC filing |
| Interim CFO | Class A Common StockSale10b5-1 | 17,775$4.39 / share | $78.03K | Aug 17Filed Aug 17 · 0d later | SEC filing |
| Chief Legal Officer | Class A Common StockGrant or award | 108,695Award · no purchase price | Non-cash award | Aug 12Filed Aug 13 · 1d later | SEC filing |
| Interim CFO | Class A Common StockGrant or award | 54,347Award · no purchase price | Non-cash award | Aug 12Filed Aug 13 · 1d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 87,798$4.65 / share | $408.26K | Aug 10Filed Aug 10 · 0d later | SEC filing |
| Chief Legal Officer | Class A Common StockSale10b5-1 | 51,700$4.51 / share | $233.17K | Jul 20Filed Jul 20 · 0d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 4,839$4.53 / share | $21.92K | Jul 17Filed Jul 17 · 0d later | SEC filing |
| Chief Executive Officer | Class A Common StockSale10b5-1 | 62,711$4.67 / share | $292.86K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| CEO, Counterpart Health | Class A Common StockSale10b5-1 | 24,215$4.67 / share | $113.08K | Jul 15Filed Jul 16 · 1d later | SEC filing |
| CEO, Medicare Advantage | Class A Common StockSale10b5-1 | 13,119$4.67 / share | $61.27K | Jul 15Filed Jul 16 · 1d later | SEC filing |
Showing the latest 20 of 49 trades. Show all 49 trades
This reflects the filings imported so far, not a complete trading history.